Author

S. Kung

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:host-pathogen & immune response· 3 Organism:mouse· 3 Research Focus:drug response / drug discovery· 1 Assay:flow cytometry· 1 Assay:metabolomics· 1 Assay:multiome· 1 Assay:proteomics· 1

Frequent Co-Authors

D. Kobasa· 2 shared X. Yao· 2 shared Z. Ao· 2 shared A. Halayko· 1 shared A. Soussi Gounni· 1 shared B. Warner· 1 shared C. Shieh· 1 shared I. Okwor· 1 shared

Activity by Year

2021-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

D. Kobasa

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

PlexinD1 deficiency in CD11c+ dendritic cells exacerbates airway hyperresponsiveness and enhances IgE and mucus production in allergic asthma

L. shan, M. Matloubi, I. Okwor, S. Kung, M. S. Almiski, S. Basu, A. Halayko, L. Koussih, A. Soussi Gounni

bioRxiv · Sep 11, 2023 · PreprintImmunology

Oral immunization with rVSV bivalent vaccine elicits protective immune responses, including ADCC, against both SARS-CoV-2 and Influenza A viruses

M. J. Ouyang, Z. Ao, T. Olukitibi, P. Lawrynuik, C. Shieh, S. Kung, K. Fowke, D. Kobasa, X. Yao

bioRxiv · Jul 14, 2023Microbiology

Development and Characterization of Recombinant Vesicular Stomatitis Virus (rVSV)-based Bivalent Vaccine Against COVID-19 Delta Variant and Influenza Virus

Z. Ao, M. Jing Ouyang, T. A. Olukitibi, B. Warner, R. Vendramelli, T. Truong, M. Zhang, S. Kung, K. R. Fowke, D. Kobasa, X. Yao

This study develops and tests a bivalent rVSV vaccine targeting SARS-CoV-2 Delta and influenza, showing strong immune responses and protection in animal models.

bioRxiv · Dec 14, 2021 · PreprintMicrobiology